skip to Main Content

Latest news

Bowman Heiden will be discussing Private Ordering Mechanisms in Patent-Intensive Markets

Bowman Heiden will be discussing Private Ordering Mechanisms in Patent-Intensive Markets with David Kappos, Luke McLeroy, Jonathan Barnett, and Sean O'Connor at the upcoming Center…

Read more

CIP FORUM 2020 (virtual) Berkeley: Dec 7th-11th

The CIP FORUM is our flagship event where CIP Partners, colleagues, alumni, and invited guests to gather biennially to address the key industry, university, and…

Read more

New course on IP & Innovation at UC Berkeley

Lee Fleming, Matt Rappaport, and Bowman Heiden recently launched a new course at University of California, Berkeley, on IP & Innovation: Analysis, Strategy, and Management in collaboration…

Read more

Upcoming seminar “Aligning IP & Business Strategy”

Join Bowman Heiden, Annya Dushine, Jennifer Karr, Stephanie Sanders, Franck Lancien, and Simonne Corriveau for this upcoming webinar

Read more

Bowman Heiden’s latest paper on The Value of Cellular Connectivity

See Bowman Heiden's latest paper on The Value of Cellular Connectivity - From Mobile Devices to the Internet of Things (IOT) now available on SSRN

Read more

Licensing 2.0 in IAM’s cover, by Gustav Brismark and Bowman Heiden

Gustav Brismark and Bowman Heiden have recently published an article in IAM - Informing IP value on the future of licensing, called Licensing 2.0 (as seen…

Read more

Tim Smith and our partner, Rouse, have launched a new initiative on the IP Team of 2025.

Tim Smith and our partner, Rouse, have launched a new initiative on the IP Team of 2025. CIP has always had a strong focus on the transformation…

Read more

Bowman Heiden participates in joint LES/EPO event

Bowman Heiden participates in the webinar for a behind-the-scenes look at the joint LES/EPO special edition of les Nouvelles dedicated to high‐growth technology businesses that…

Read more

Paul Fehlner, writes about IP and open innovation in Pharma

Our advisory board member, Paul Fehlner, has written an insightful article about IP and open innovation in Pharma. It is important to note that designing the…

Read more

Bowman Heiden, has co-authored two papers included in this special EPO issue

Our Director, Bowman Heiden, has co-authored two papers included in this EPO issue (together with Ruud Peters, Thomas Bereuter, CLP, Adéla Dvořáková, and Juergen Graner). The issue is available…

Read more

Hoover publication by Bowman Heiden and Richard Sousa: ‘Connected’ In a Time Of COVID

Hoover has recently published 'Connected' In a Time Of COVID, by Bowman Heiden and Richard Sousa. The article highlights the importance of high-tech communications in areas…

Read more